Erythropoiesis-stimulating agents—time for a reevaluation

EF Unger, AM Thompson, MJ Blank… - New England Journal …, 2010 - Mass Medical Soc
EF Unger, AM Thompson, MJ Blank, R Temple
New England Journal of Medicine, 2010Mass Medical Soc
Randomized trials have endeavored to show that using ESAs to raise hemoglobin
concentrations to higher targets improves clinical outcomes in patients with anemia
associated with chronic kidney disease. Dr. Ellis Unger and FDA colleagues describe the
trial results, which have suggested the opposite.
Randomized trials have endeavored to show that using ESAs to raise hemoglobin concentrations to higher targets improves clinical outcomes in patients with anemia associated with chronic kidney disease. Dr. Ellis Unger and FDA colleagues describe the trial results, which have suggested the opposite.
The New England Journal Of Medicine